Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases

Details for Australian Patent Application No. 2010254160 (hide)

Owner Abbott Laboratories

Inventors Bruncko, Milan; Ding, Hong; Doherty, George; Elmore, Steven; Hasvold, Lisa; Hexamer, Laura; Kunzer, Aaron R.; Song, Xiaohong; Souers, Andrew J.; Sullivan, Gerard; Tao, Zhi-Fu; Wang, Gary T.; Wang, Le; Wang, Xilu; Wendt, Michael; Mantei, Robert; Hansen, Todd M.

Agent Spruson & Ferguson

Pub. Number AU-A-2010254160

PCT Pub. Number WO2010/138588

Priority 61/181,203 26.05.09 US

Filing date 26 May 2010

Wipo publication date 2 December 2010

International Classifications

C07D 471/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

Event Publications

24 November 2011 PCT application entered the National Phase

  PCT publication WO2010/138588 Priority application(s): WO2010/138588

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010254161-Bicyclic pyrimidine PI3K inhibitor compounds selective for p110 delta, and methods of use

2010254155-Method of producing naturally purified salt products